Four-Branch Dendrimer PEG Conjugation for Protein Stability
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current PEGylation methods using monomethoxypolyethylene glycol (mPEG) face limitations in achieving high molecular mass conjugates without crosslinking issues, leading to suboptimal biological activity and stability of therapeutic proteins, particularly due to the difficulty in controlling polymerization of long chains and the presence of a diol fraction in higher molecular mass mPEG.
Innovation Solution
A dendrimer-like polymeric structure with four branches of polyethylene glycol (PEG) is developed, allowing for the synthesis of conjugates with molecular masses up to 120 kDa, which enhances stability and homogeneity, and reduces diol contamination, using a two-step process involving the activation of linear PEG chains and their attachment to a core molecule like lysine, followed by further branching.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Duration of action of stationary object
If monomethoxypolyethylene glycol (mPEG) of higher molecular mass is used for conjugation, then the blood residence time and stability of the conjugate increase, but the control of polymerization becomes difficult and diol fraction increases
Solution Approach 1:
The PEG structure is segmented into multiple linear chains (2, 3, or 4 branches) of controlled molecular mass (5-30 kDa each), connected to a core molecule. This segmentation allows each individual PEG chain to be synthesized with precise control, while the overall conjugate achieves high molecular mass (20-120 kDa) for extended blood residence time. The segmented structure eliminates the polymerization control difficulties associated with synthesizing single long PEG chains.
2Productivity
If bifunctional or polyfunctional reagents are used for protein conjugation, then the conjugation efficiency increases, but crosslinking occurs that affects biological activity
Solution Approach 1:
The dendrimer-like PEG structure acts as an intermediary between the protein and the polymeric residue. The core molecule (e.g., lysine derivative) provides controlled attachment points to the protein, while the multiple linear PEG branches extend outward to provide steric protection. This intermediary structure achieves efficient conjugation without the crosslinking problems of bifunctional reagents, as the linear PEG chains cannot form crosslinks between protein molecules.
3Object-affected harmful factors
If extensive PEGylation is achieved using traditional reagents, then the stability against proteases improves, but biological activity decreases due to blocking of active sites
Solution Approach 1:
The dendrimer-like PEG structure provides local quality differentiation: the core region attaches to the protein with controlled stoichiometry (preferably 1:1 or low ratios), while the multiple linear PEG branches extend outward to provide steric protection at the periphery. This spatial distribution ensures that PEG residues protect against proteases without extensively blocking the protein's active sites, thereby maintaining biological activity while improving stability.
Data Source
Figure 1~2
AI summary
A polymeric dendrimer-like structure with four branches of monomethoxypolyethylene glycol that can be represented as: The carboxylic group of the previous structure can be functionalized for the production of conjugates of pharmaceutical interest. The binding of this dendrimer-like polyethylene glycol to therapeutic proteins improves their in vitro and in vivo stability.